Medicaid Is Not A Test Lab For Foreign Price Controls
- Bias Rating
-4% Center
- Reliability
65% ReliableAverage
- Policy Leaning
-4% Center
- Politician Portrayal
-1% Negative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
-1% Negative
- Liberal
- Conservative
Sentence | Sentiment | Bias |
---|---|---|
Unlock this feature by upgrading to the Pro plan. |
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative

Contributing sentiments towards policy:
62% : MFN proponents like to frame the policy as a way to stop "foreign freeloading."58% : Medicaid doesn't need price controls from other countries; it already imposes them here.
57% : Medicaid receives average discounts exceeding 50%.
56% : But we don't have to speculate -- decades of data already show what price controls do to innovation.
53% : The MFN proposal isn't tough on foreign freeloaders.
52% : Rep. Chip Roy, R-Texas, and 19 of his House colleagues have outlined exactly the right approach: restore fiscal responsibility to Medicaid through block grants or per-capita caps, tighten eligibility verification, and align incentives with outcomes.
51% : Instead of doubling down on price controls, Republicans should get serious about structural Medicaid reform.
47% : Under the program's existing "Best Price" rule, manufacturers must offer Medicaid the lowest price they give to any other buyer, plus pay steep, mandatory rebates.
47% : In practice, this could force companies to stop offering their drugs in Medicaid entirely.
47% : It would make Medicaid more expensive, less effective, and more dangerous -- not just to patients, but to the future of American medicine.
46% : In a desperate bid to claim fiscal discipline without touching entitlements, President Donald J. Trump is pushing congressional Republicans to adopt a "most favored nation" (MFN) drug pricing model for Medicaid.
45% : Importing foreign price controls is not a clever budget tactic.
44% : This policy would tie Medicaid reimbursements to the lowest prices paid in other developed countries -- countries where government officials dictate drug prices under threat of coercion, patent confiscation, or market exclusion.
43% : And thanks to federal law, exiting Medicaid also means forfeiting Medicare Part B coverage.
43% : One act of economic illiteracy would therefore sabotage both Medicaid and Medicare simultaneously.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.